On August 26, 2019 Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, reported Marty Duvall, chief executive officer, will present and webcast at the Baird 2019 Global Healthcare Conference in New York on Wednesday, September 4 at 2:30 PM Eastern (Press release, Tocagen, AUG 26, 2019, View Source [SID1234538980]). In addition, Tocagen will participate in Citi’s 14th Annual Biotech Conference in Boston on September 5.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live audio webcast from the Baird Conference and subsequent replay may be accessed by visiting Tocagen’s website. The webcast will be available shortly after conclusion of the presentation and archived on the company’s website for 30 days following the presentation.